IP Library Granted Patent US 11,899,008
Granted Patent B2
US 11,899,008 · App. 17/527,038 · Granted Feb 13, 2024

Blood state analysis apparatus, blood state analysis system, blood state analysis method, and program

Inventors: Marcaurele Brun (Tokyo, JP); Yoshihito Hayashi (Chiba, JP)
Assignee: Sony Group Corporation
G01N33/4905G01N27/02G01N27/22G01N33/6896G01N33/86G01N2333/75G01N2440/14G01N2800/2821
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,899,008
App. No.
17/527,038
Granted
Feb 13, 2024
Kind
B2
Abstract

A blood state analysis apparatus including at least an analysis unit that uses data related to the temporal change in electrical characteristics to analyze information related to fibrinogen in a blood sample, in which the analysis unit uses at least two predetermined time points derived from the data related to the temporal change on a basis of a predetermined mathematical definition to calculate a parameter R, and acquires at least two pieces of information related to the fibrinogen in the blood sample.

Claims (17)

1. A blood state analysis method comprising:

acquiring, based on a parameter R, at least two pieces of information related to fibrinogen in a blood sample,

calculating the parameter R based on a predetermined mathematical definition, using at least two predetermined time points derived from data related to a temporal change in electrical characteristics of the blood sample;

analyzing the at least two pieces of information using the data related to the temporal change in the electrical characteristics of the blood sample,

wherein the electrical characteristics comprise at least one dielectric constant at frequencies of 500 kilohertz to 10 megahertz and

selecting the at least two pieces of information from information related to a total amount of fibrinogen, information related to an amount of fibrinogen involved in blood clotting, and information related to a polymerization ability of fibrinogen.

2. The blood state analysis method according to claim 1 , further comprising: selecting the at least two predetermined time points from a list including:

(i) a time point when the electrical characteristics have a maximum value or a minimum value, or a time point when a change in the electrical characteristics exceeds a predetermined threshold value,

(ii) a time point when the change in the electrical characteristics exceeds a predetermined change rate set in advance, or a time point when the change in the electrical characteristics falls below the predetermined change rate set in advance,

(iii) a time point when the change in the electrical characteristics is the maximum or a middle time point between the (i) and the (ii), and

(iv) a time point when a maximum change rate is obtained between the (i) and the (ii).

3. The blood state analysis method according to claim 2 , wherein the method comprises:

comparing the at least two predetermined time points selected from the (i) to (iv) with each other on a basis of a predetermined starting point.

4. The blood state analysis method according to claim 1 , wherein the method comprises:

using a derivative to calculate a parameter S, the derivative being obtained at a time point before the electrical characteristics have a maximum value or a minimum value.

5. The blood state analysis method according to claim 1 , wherein the method comprises:

using the data includes using a blood clotting amplitude to calculate a parameter A, the blood clotting amplitude being obtained at a predetermined time point.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2022
From: BRUN, MARCAURELE; HAYASHI, YOSHIHITO
To: SONY CORPORATION
Reel/Frame 059031/0489 →
CHANGE OF NAME Recorded Feb 17, 2022
From: SONY CORPORATION
To: SONY GROUP CORPORATION
Reel/Frame 059171/0705 →
Priority Claims (1)
JP 2016-068369 · Mar 30, 2016 · national
Continuity (2)
Division 16086943
Related Publication 20220074921A1 · Mar 10, 2022